Sign In | Join Free | My tjskl.org.cn
China Orient New Life Medical Co.,Ltd. logo
Orient New Life Medical Co.,Ltd.
Orient New Life Medical Co.,Ltd. Quality is life.
Active Member

9 Years

Home > Mouse Monoclonal Antibody >

Recombinant COVID-19 Mouse Monoclonal Antibody (Mab) Therapy

Orient New Life Medical Co.,Ltd.
Contact Now

Recombinant COVID-19 Mouse Monoclonal Antibody (Mab) Therapy

  • 1
  • 2
  • 3

Brand Name : New Life

Model Number : 40021-T62

Certification : ISO13485

Place of Origin : China

MOQ : 1mg

Price : USD

Payment Terms : T/T, Western Union

Supply Ability : 1111mg/month

Delivery Time : 10-35days

Packaging Details : 0.5mg/tube 1mg/tube, 2mg/tube、5mg/tube、10mg/tube、20mg/tube、30mg/tube

Category : Ab Monoclonal

Application : Covid-19 Monoclonal

Usage : ELISA

Specimen : Blood

Shelf Life : 12 months

Concerntraion : 1mg

Contact Now

Recombinant COVID-19 Mouse monoclonal antibody (mab) therapy

Background

The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell. Known receptors bind S1 are ACE2, angiotensin-converting enzyme 2; DPP4, dipeptidyl peptidase-4; APN, aminopeptidase N; CEACAM, carcinoembryonic antigen-related cell adhesion molecule 1; Sia, sialic acid; O-ac Sia, O-acetylated sialic acid. The spike is essential for both host specificity and viral infectivity. The term 'peplomer' is typically used to refer to a grouping of heterologous proteins on the virus surface that function together. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. It's been reported that SARS-CoV-2 (COVID-19 coronavirus, 2019-nCoV) can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

Name

COVID-19 Mouse Monoclonal Antibody

40021-T62 Recombinant HCoV-HKU1 Spike Protein

Application Invitro research and manufacture use;
membrane assay, ELISA assay,
Formulation 0.2 μm filtered solution in PBS Buffer: 1X PBS buffer
Storage: This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative- Free. Avoid repeated freeze-thaw cycles. Concentration

WB: 1:1000-1:5000

ELISA: 1:5000-1:10000

Expiration Date: 30 days refrigerated at -2-8ºC
and twelve months frozen at -20 ºC
or below from production date.
To be evaluated independently
Feature High Sensitivity and Specificity

Specification Data

Description: Recombinant HCoV-HKU1 Spike Protein
Clone: SARS-CoV-2 (2019-nCoV) Spike RBD Protein
Source: Rabbit IgG
Immunogen:

HCoV-HKU1 (isolate N1) Spike S1 Protein

HCoV-HKU1 (isolate N5) Spike S1 Protein

HCoV-NL63 Spike S1 Protein

Formulation:

0.22 μm filtered solution in Histidine and Arginine buffer containing 120mM NaCl, 0.02% Tween 80

Purification: DEAE chromatography
Concentration: 1.0 mg/mL (OD280 nm, E0.1% = 1.40)
Affinity Constant: Not determined
Buffer: 0.015M potassium phosphate buffer, 0.85% NaCl, 0.05% NaN3 pH=7.2
Pairing Assays: N/A
Purity: >95% by HPLC and SDS-PAGE
Application:

WB, ELISA, IHC-P, FCM, ICC/IF, IP

IHC, FCM, IF, IP et al. applications haven't been validated. (Antibody's applications haven't been validated with corresponding virus positive samples. Optimal concentrations/dilutions should be determined by the end user.)

Information on toxicological effects

Acute toxicity:No data available.

Skin corrosion/irritation: No data available

Serious eye damage/eye irritation: No data available.

Sensitization : No sensitizing effects known.

Specific target organ toxicity - repeated exposure: No data available.

Aspiration hazard: No data available.

Additional Information: Not available.

Recombinant COVID-19 Mouse Monoclonal Antibody (Mab) Therapy

FAQ

1. Q:Are you a factory or trading company?
A: We are a factory, we have rich experience for manufacturing Medical Device more than 10 years.
2.Q:Where is your factory located? How can i visit there?
A: Our factory is located in Jiaxing city, Zhejiang Province, China.
It is about more than 1 hours from Shanghai.

2. 3.Q:Can you make samples?
A: Yes, we can make samples for you.
4.Q:How does your factory do as quality control?
A: Quality is the lift of our factory. We have inspector in different post, and there are three inspectors before packing to get best quality products.
5.Q: How is your post market service ?
A: If any damaged rings in the course of carriage, with the checking it's our mistake, we will take full responsibility to compensate the customers.

6.Q:Can you do OEM for us?
A: Certainly. We also can build the moulding for our new customer.

7.Q:Does the price include freight?
A:No, please choose the express service provider or negotiate with us.


Product Tags:

0.2μm Filtered Mouse Monoclonal Antibody

      

Spike S1 Protein Mouse Monoclonal Antibody

      

5mg/tube Mab Monoclonal Antibody

      
Quality Recombinant COVID-19 Mouse Monoclonal Antibody (Mab) Therapy for sale

Recombinant COVID-19 Mouse Monoclonal Antibody (Mab) Therapy Images

Inquiry Cart 0
Send your message to this supplier
 
*From:
*To: Orient New Life Medical Co.,Ltd.
*Subject:
*Message:
Characters Remaining: (0/3000)